RxDoctor Payments Data

Andrew Cohen, DPM

Podiatrist · Saginaw, MINPI 1902845290

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by In2bones USA, LLC at 52.7% of the total. Reporting peaked in 2022 at $3,251 and has fallen 87.0% since, to $421 in 2025. Among podiatrist clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,471in general payments, 2019–2025

Across 76 payments — averaging $124.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • In2bones USA, LLC$5K
  • Stryker$2K
  • Linvatec Corporation$529
  • Paragon 28, Inc.$400
  • Johnson & Johnson$216
  • Urgo Medical North America, LLC$200
  • plus $1K from 13 others

What the payments were for

  • Speaking & faculty fees$4,09343%
  • Travel & lodging$2,60728%
  • Food & beverage$2,68328%
  • Education$881%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,471 in reported general payments places this provider in the 90th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$375,310
Medicare patients
215
Services billed
1,902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox44$805
Gabapentin55$802
Ammonium Lactate43$446
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav33$399
Tramadol Hcl21$306
Ciprofloxacin Hcl36$210
Cephalexin33$209
Doxycycline Monohydrate15$192
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$131
Silver Sulfadiazine11$81
SsdSilver Sulfadiazine20$63

Paid to pharmacies, not to this prescriber.

Other podiatrist in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →